Stock Here is the 2025 global real estate outlook according to RBC by December 21, 2024 by December 21, 2024 Investing.com — In its report titled “2025 Global Real Estate Outlook,” RBC Capital Markets said it anticipates diverging paths for… 0 FacebookTwitterPinterestEmail
Stock U.S. housing market to improve in 2025, but challenges persist by December 21, 2024 by December 21, 2024 Investing.com — The U.S. housing market is expected to see mild improvements in 2025, but elevated mortgage rates and affordability challenges… 0 FacebookTwitterPinterestEmail
Stock GLP-1: Barclays on why 2025 could be an inflection point by December 21, 2024 by December 21, 2024 Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management,… 0 FacebookTwitterPinterestEmail
Stock Honda and Nissan consider mutual production of vehicles, Kyodo reports by December 21, 2024 by December 21, 2024 TOKYO (Reuters) – Honda (NYSE:HMC) and Nissan (OTC:NSANY) are considering producing vehicles in one another’s factories as part of their… 0 FacebookTwitterPinterestEmail
Stock Google says it could loosen search deals in US antitrust case by December 21, 2024 by December 21, 2024 By Jody Godoy (Reuters) – Alphabet (NASDAQ:GOOGL)’s Google proposed on Friday a loosening of its agreements with Apple (NASDAQ:AAPL) and… 0 FacebookTwitterPinterestEmail
Stock US judge finds Israel’s NSO Group liable for hacking in WhatsApp lawsuit by December 21, 2024 by December 21, 2024 TORONTO (Reuters) – A U.S. judge ruled on Friday in favor of Meta (NASDAQ:META) Platform Inc’s WhatsApp in a lawsuit… 0 FacebookTwitterPinterestEmail
Stock House Democrat says Republicans protecting Elon Musk’s Chinese investments by December 21, 2024 by December 21, 2024 By David Shepardson WASHINGTON (Reuters) -The top Democrat on the House of Representatives Appropriations Committee said on Friday that Republicans… 0 FacebookTwitterPinterestEmail
Stock Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea by December 21, 2024 by December 21, 2024 By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for… 0 FacebookTwitterPinterestEmail
Stock US finalizes up to $6.75 billion in chips awards for Samsung, Texas Instruments, Amkor by December 21, 2024 by December 21, 2024 By David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department said on Friday it was finalizing an award of up to… 0 FacebookTwitterPinterestEmail
Stock US, Israeli officials deny approving sale of Israeli spyware firm to US investors by December 21, 2024 by December 21, 2024 By Raphael Satter and AJ Vicens WASHINGTON (Reuters) – Officials in the United States and Israel have denied reports their… 0 FacebookTwitterPinterestEmail
